$NRIX

Nurix Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Brisbane, CA

NRIX chart

What traders are saying about $NRIX

Latest posts

Nurix Therapeutics, Inc. news

Nurix Therapeutics, Inc. key financials

USD2025202420232022
Revenue$84.0M$54.5M$77.0M$38.6M
Net income-$264.5M-$193.6M-$143.9M-$180.4M
Diluted EPS$-3.05$-2.88$-2.65$-3.71
Total assets (year end)$688.1M$669.3M$355.6M$416.8M
Cash and equivalents (year end)$247.0M$110.0M$54.6M$64.5M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Nurix Therapeutics, Inc.

Ticker
NRIX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Brisbane, CA
Incorporated in
DE
Fiscal year end
November 30
SEC CIK
1549595
Former names
Nurix, Inc.

Frequently asked questions

What exchange is Nurix Therapeutics, Inc. listed on?

Nurix Therapeutics, Inc. trades on the Nasdaq under the ticker symbol NRIX.

What industry is Nurix Therapeutics, Inc. in?

Nurix Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Nurix Therapeutics, Inc. headquartered?

Nurix Therapeutics, Inc.'s business address on file with the SEC is in Brisbane, CA.

When does Nurix Therapeutics, Inc.'s fiscal year end?

Nurix Therapeutics, Inc.'s fiscal year ends on November 30.

How much revenue did Nurix Therapeutics, Inc. report?

Nurix Therapeutics, Inc. reported $84.0M in revenue for calendar year 2025, according to its SEC filings.